FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,161 | -55.5% | 18,472 | 0.0% | 0.07% | -60.9% |
| Q2 2023 | $87,927 | -16.5% | 18,472 | 0.0% | 0.17% | -11.1% |
| Q1 2023 | $105,290 | -67.6% | 18,472 | -42.7% | 0.19% | -71.5% |
| Q4 2022 | $325,443 | +2.3% | 32,254 | +127.7% | 0.67% | +2.6% |
| Q3 2022 | $318,000 | -14.3% | 14,165 | -4.9% | 0.65% | +60.9% |
| Q2 2022 | $371,000 | -20.9% | 14,889 | +23.1% | 0.40% | +16.1% |
| Q1 2022 | $469,000 | -53.1% | 12,095 | -29.1% | 0.35% | -65.0% |
| Q4 2021 | $999,000 | -15.3% | 17,066 | -14.3% | 0.99% | +12.6% |
| Q3 2021 | $1,180,000 | +372.0% | 19,910 | +623.5% | 0.88% | +472.7% |
| Q4 2020 | $250,000 | – | 2,752 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |